364 related articles for article (PubMed ID: 34323012)
21. What Are Factors Contributing to Improvement of Overactive Bladder Symptoms after Alpha-1 Blocker Treatment in Patients with Both Storage and Voiding Symptoms?
Matsukawa Y; Majima T; Takai S; Funahashi Y; Kato M; Gotoh M
Urol Int; 2019; 103(4):439-443. PubMed ID: 31554005
[TBL] [Abstract][Full Text] [Related]
22. Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.
Brock G; Broderick G; Roehrborn CG; Xu L; Wong D; Viktrup L
BJU Int; 2013 Nov; 112(7):990-7. PubMed ID: 23937669
[TBL] [Abstract][Full Text] [Related]
23. Is periurethral calcification associated with urinary flow rate and symptom severity in men with lower urinary tract symptoms-benign prostatic hyperplasia? A retrospective review.
Han JH; Kwon JK; Lee JY; Kang DH; Choi HC; Lee JS; Cho KS
Urology; 2015 May; 85(5):1156-1161. PubMed ID: 25818911
[TBL] [Abstract][Full Text] [Related]
24. Tamsulosin plus a new complementary and alternative medicine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a retrospective comparative study.
Fusco F; Creta M; Trama F; Esposito F; Crocetto F; Aveta A; Mangiapia F; Imbimbo C; Capece M; La Rocca R; Mirone V; Longo N
Arch Ital Urol Androl; 2020 Oct; 92(3):. PubMed ID: 33016038
[TBL] [Abstract][Full Text] [Related]
25. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
[TBL] [Abstract][Full Text] [Related]
26. Epidemic investigation of benign prostatic obstruction with coexisting overactive bladder in Shanghai Pudong New Area and its impact on the health-related quality of life.
Yi QT; Gong M; Chen CH; Hu W; Zhu RJ
BMC Urol; 2019 Sep; 19(1):82. PubMed ID: 31481034
[TBL] [Abstract][Full Text] [Related]
27. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A;
Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723
[TBL] [Abstract][Full Text] [Related]
28. Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).
Takahashi R; Miyazato M; Nishii H; Sumino Y; Takayama K; Onzuka M; Oshiro T; Saito S; Fujimoto N; Mimata H; Eto M
Low Urin Tract Symptoms; 2018 Jan; 10(1):76-83. PubMed ID: 29341501
[TBL] [Abstract][Full Text] [Related]
29. Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms?
Cornu JN; Grise P
Curr Opin Urol; 2016 Jan; 26(1):17-21. PubMed ID: 26574877
[TBL] [Abstract][Full Text] [Related]
30. International Prostate Symptom Score for assessing lower urinary tract dysfunction in women.
Hsiao SM; Lin HH; Kuo HC
Int Urogynecol J; 2013 Feb; 24(2):263-7. PubMed ID: 22588143
[TBL] [Abstract][Full Text] [Related]
31. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
[TBL] [Abstract][Full Text] [Related]
32. New and Emerging Technologies in Treatment of Lower Urinary Tract Symptoms From Benign Prostatic Hyperplasia.
Gupta NK; Gange SN; McVary KT
Sex Med Rev; 2019 Jul; 7(3):491-498. PubMed ID: 29606553
[TBL] [Abstract][Full Text] [Related]
33. Impact of serum 25-OH vitamin D level on lower urinary tract symptoms in men: a step towards reducing overactive bladder.
Yoo S; Oh S; Kim HS; Choi HS; Park J; Cho SY; Son H; Jeong H; Lee HW; Cho MC
BJU Int; 2018 Oct; 122(4):667-672. PubMed ID: 29745000
[TBL] [Abstract][Full Text] [Related]
34. Undertreatment of overactive bladder among men with lower urinary tract symptoms in the United States: A retrospective observational study.
Burnett AL; Walker DR; Feng Q; Johnston KM; Lozano-Ortega G; Nimke D; Hairston JC
Neurourol Urodyn; 2020 Jun; 39(5):1378-1386. PubMed ID: 32383533
[TBL] [Abstract][Full Text] [Related]
35. [Expression of brainderived neurotrophic factor in urine of patients with benign prostatic hyperplasia complicated overactive bladder symptoms].
Hu H; Xu KX; Zhang XP; Fang ZW; Chen JW; Huo F; Wang D; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 46(4):519-23. PubMed ID: 25131461
[TBL] [Abstract][Full Text] [Related]
36. Safety and effectiveness of mirabegron in male patients with overactive bladder with or without benign prostatic hyperplasia: A Japanese post-marketing study.
Takahashi S; Kato D; Tabuchi H; Uno S
Low Urin Tract Symptoms; 2021 Jan; 13(1):79-87. PubMed ID: 32761776
[TBL] [Abstract][Full Text] [Related]
37. Change in Postoperative Storage Symptoms and
Castellani D; Di Rosa M; Saredi G; Pacchetti A; Banchero R; Ambrosini F; Meroni P; Guano G; Boltri M; Bucci S; Simonetti E; Maestroni UV; Ferretti S; Terrone C; Dellabella M
J Endourol; 2022 Sep; 36(9):1223-1230. PubMed ID: 35414264
[No Abstract] [Full Text] [Related]
38. Survey of overactive bladder symptoms influencing bother before and after treatment with tamsulosin hydrochloride in Japanese patients with benign prostatic hyperplasia.
Tsujimura A; Takao T; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Ueda T; Kiuchi H; Hirai T; Tsujimoto Y; Miura H; Kanno N; Higashino M; Nakamura Y; Nishimura K; Nonomura N
Urology; 2011 Nov; 78(5):1058-62. PubMed ID: 21908025
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and Safety of Mirabegron in Men with Overactive Bladder Symptoms and Benign Prostatic Hyperplasia.
Mullen GR; Kaplan SA
Curr Urol Rep; 2021 Jan; 22(1):5. PubMed ID: 33411109
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of peripheral zone thickness in men with lower urinary tract symptoms/benign prostatic hyperplasia.
Kwon JK; Han JH; Choi HC; Kang DH; Lee JY; Kim JH; Oh CK; Choi YD; Cho KS
BJU Int; 2016 Feb; 117(2):316-22. PubMed ID: 25807886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
